Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Internal Medicine
Allergy & Immunology
Questions discussed in this category
Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?
Omalizumab has been reported as a possible provoking factor for venous thromboembolism.
2 Answers available
Have you observed adverse mental health side effects in patients who start montelukast?
In light of the FDA warning about mental health side effects of the medication have you observed in particular any patients develop suicidal thoughts ...
1 Answer available
22592
22082
Related Topics in Internal Medicine
Dermatology
Primary Care
General Internal Medicine
Infectious Disease
Psychiatry
Hematology
General Infectious Disease
Cardiology
Advanced Heart Failure and Transplant
Allergy & Immunology